ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Basic/Clinical Science Session

Glomerular Disease Pathogenesis: What's New?

October 24, 2020 | 02:30 PM - 04:30 PM

Location: Simulive

Session Description

Taken together, primary and secondary glomerular diseases account for 90% of all ESKD in the United States, at a cost in excess of $20 billion per year. The development of novel therapeutics is limited by poor understanding of the underlying disease pathogenesis. This session highlights novel and emerging concepts driving the understanding of cellular injury, degeneration, and cross-talk that could help advance the quest for better treatment options.

Learning Objective(s)

  • Identify glomerular metabolic changes in hypertensive nephropathy
  • Define mechanisms underlying pathogenic endothelial-podocyte cross-talk
  • Discuss the contribution of lipids to glomerular disease progression
  • Describe the pathogenesis of immune-mediated podocyte injury

Learning Pathway(s)

  • Glomerular Diseases
  • Pathology

Moderators

  • Kyung Lee, PhD
  • Joshua M. Thurman, MD

Presentations

  • Glomerular Metabolic Changes in Hypertensive Kidney Disease
    02:30 PM - 03:00 PM
    Markus M. Rinschen, MD
  • Mechanism of Pathogenic Podocyte-Endothelial Cross-Talk
    03:00 PM - 03:30 PM
    Ilse S. Daehn, PhD, FASN 
  • Immune-Mediated Podocyte Injury: Pathogenesis and Therapeutic Opportunities
    03:30 PM - 04:00 PM
    Eunsil Hahm, PhD
  • Lipids in Cellular Injury and Glomerular Disease
    04:00 PM - 04:30 PM
    Sandra M. Merscher, PhD